Repurposing drugs, ongoing vaccine and new therapeutic development initiatives against COVID-19 RP Saha, MK Singh, S Samanta, S Bhakta, S Mandal, M Bhattacharya, ... Frontiers in Pharmacology 11, 1258, 2020 | 123 | 2020 |
Metal homeostasis in bacteria: the role of ArsR–SmtB family of transcriptional repressors in combating varying metal concentrations in the environment RP Saha, S Samanta, S Patra, D Sarkar, A Saha, MK Singh BioMetals, 1-45, 2017 | 47 | 2017 |
Bioactivity guided fractionation of Moringa oleifera Lam. flower targeting Leishmania donovani MK Singh, J Paul, T De, T Chakraborti Indian Journal Of Experimental Biology 53 (11), 747-752, 2015 | 28 | 2015 |
Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB MK Singh, SK Bhaumik, S Karmakar, J Paul, S Sawoo, HK Majumder, ... Experimental Parasitology 175, 8-20, 2017 | 24 | 2017 |
Virulence attenuation of a UDP-galactose/N-acetylglucosamine β1, 4 galactosyltransferase expressing Leishmania donovani promastigote SK Bhaumik, M Singh, R Basu, S Bhaumik, K Roychoudhury, K Naskar, ... Glycoconjugate journal 25 (5), 459-472, 2008 | 12 | 2008 |
Applications of Artificial Intelligence in Healthcare S Quazi, RP Saha, MK Singh Journal of Experimental Biology and Agricultural Sciences, 211-226, 2022 | 8 | 2022 |
UDP-Gal: N-acetylglucosamine β 1–4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis SK Bhaumik, MK Singh, S Karmakar, T De Glycoconjugate journal 26 (6), 663-673, 2009 | 7 | 2009 |
Effects of Food Production and Consumption on Environment and Climate S Sen, MK Singh, A Das Advances in Medical Physics and Healthcare Engineering, 361-370, 2021 | 5 | 2021 |
Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera SK Bhaumik, MK Singh, S Karmakar, T De Molecular and biochemical parasitology 159 (2), 121-129, 2008 | 5 | 2008 |
Avian influenza virus: Prevalence infection and therapy AD Anirban Debnath, Abinit Saha, Manoj Kumar Singh, Rudra P. Saha Viral, Parasitic, Bacterial, and Fungal Infections, 141-149, 2023 | 1 | 2023 |
Artificial Womb Technology: A Roadmap to a changing Medico-Legal Landscape SK Singh, A Dey, S Putatunda, MK Singh Journal of Experimental Biology and Agricultural Sciences, 201-210, 2022 | 1 | 2022 |
The bacteriophage mu lysis system–A new mechanism of host lysis? S Samanta, AR Sharma, A Saha, MK Singh, A Das, M Bhattacharya, ... Biocell 45 (5), 1175, 2021 | 1 | 2021 |
ARTIFICIAL INTELLIGENCE IN TACKLING CORONAVIRUS AND FUTURE PANDEMICS MKS Shagufta Quazi, Sampa Karmakar Singh, Rudra Prasad Saha, Arpita Das Journal of Experimental Biology and Agricultural Sciences 12 (1), 124-137, 2024 | | 2024 |
Prokaryotic ncRNAs: Master regulators of gene expression R Majumder, S Ghosh, A Das, MK Singh, S Samanta, A Saha, RP Saha Current Research in Pharmacology and Drug Discovery, 100136, 2022 | | 2022 |
Activation of TLR-pathway to induce host Th1 immune response against visceral leishmaniasis: Involvement of galactosylated-flavonoids. J Pradhan, S., Snehlata, Manna, D., Karmakar, S., Singh, M. K., Bhattacharya ... Heliyon 8 (7), e09868, 2022 | | 2022 |
Leishmaniasis: Plants as a source of antileishmanial agents MK Singh, A Das, RP Saha, J Paul, D Nandi Journal of Experimental Biology and Agricultural Sciences, 227-247, 2022 | | 2022 |